The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Secondary outcomes by prior definitive treatment (tx) in patients (pts) with high-risk biochemically recurrent prostate cancer (hrBCR) treated with enzalutamide (enza) monotherapy (mono): EMBARK post hoc analysis.
 
Stephen Freedland
Employment - Genomic Health (I)
Stock and Other Ownership Interests - Caper Labs; Hessian Labs
Consulting or Advisory Role - A3P Biomedical; Astellas Pharma; AstraZeneca; Bayer; Caper Labs; Clovis Oncology; Dendreon; Exact Sciences; Exosome Diagnostics; Ferring; Hessian Labs; Janssen Biotech; Lilly; LynxDx; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi; Tempus; Tolmar
Speakers' Bureau - Astellas Pharma; AstraZeneca; Pfizer; Sanofi
Research Funding - Bayer (Inst); Diasorin; GenomeDx (Inst); Janssen Biotech (Inst); MDxHealth (Inst); Merck; Myriad Genetics (Inst); OPKO Diagnostics (Inst); Progenika (Inst)
Travel, Accommodations, Expenses - Sanofi
 
Ugo De Giorgi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Dompé Farmaceutici; Eisai; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer; PharmaMar
Research Funding - AstraZeneca (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; Ipsen; Merck; Pfizer
 
Ronald Tutrone
Employment - Astellas Pharma; Pfizer
Expert Testimony - Advisory board: Astellas
 
Lawrence Karsh
Stock and Other Ownership Interests - Swan Valley Medical (I)
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb/Roche; Ferring; Janssen; Merck; Pfizer
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bioxell Pharma (Inst); Bristol-Myers Squibb/Sanofi (Inst); Cleveland Diagnostics; Dendreon (Inst); Exact Sciences (Inst); Ferring (Inst); FKD Therapies (Inst); Janssen (Inst); KDx Diagnostics (Inst); Merck (Inst); Myovant Sciences (Inst); Pfizer (Inst); Tavanta Therapeutics (Inst); Vaxiion (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; dendreon; Janssen; Pfizer
 
Miguel Ramirez-Backhaus
Honoraria - Accord Healthcare; Astellas Pharma; Bayer; Johnson and Johnson
Consulting or Advisory Role - Accord Healthcare; Astellas Pharma; Bayer; Johnson & Johnson/Janssen
Travel, Accommodations, Expenses - Astellas Pharma; Johnson & Johnson/Janssen
 
Edward Uchio
Research Funding - Astellas Pharma; AstraZeneca; Bayer; Blue Earth Diagnostics; CG Oncology; Dendreon; Janssen Oncology; Merck; Pfizer; Seagen
(OPTIONAL) Uncompensated Relationships - Astellas Pharma; AstraZeneca; Bayer; Genomic Health; Janssen Oncology; Lantheus Medical Imaging; Merck; Myriad Genetics; Pfizer
 
Yiyun Tang
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Ruslan Croitoru
Employment - Astellas Pharma
 
Matt Rosales
Employment - Astellas Pharma
Stock and Other Ownership Interests - Astellas Pharma
 
Matko Kalac
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - Guidepoint Global; Seagen
Speakers' Bureau - Kyowa Kirin International
 
Fong Wang
Employment - Exelixis; Pfizer
Stock and Other Ownership Interests - Exelixis; Pfizer
 
Neal Shore
Employment - GenesisCare
Consulting or Advisory Role - Accord Research; Alessa Therapeutics; Amgen; Antev; Arquer Diagnostics; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Aura Biosciences; Bayer; Bioprotect; Bristol-Myers Squibb/Sanofi; CG Oncology; Clarity Pharmaceuticals; Dendreon; Exact Imaging; Ferring; Fize Medical; Glytherix; InVitae; Janssen Scientific Affairs; Lantheus Medical Imaging; Lilly; MDxHealth; Medivation/Astellas; Merck; Minomic; Myriad Genetics; Novartis; Peerview; Pfizer; Photocure; PlatformQ Health; Promaxo; Propella Therapeutics; Protara Therapeutics; Sanofi; Siemens; Speciality Networks; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tolmar; Tutelix; Urogen pharma
Research Funding - Abbvie; Advantagene; Amgen; Aragon Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; CG Oncology; Clovis Oncology; Dendreon; DisperSol; Endocyte; Exact Imaging; Exelixis; Ferring; FKD Therapies; FORMA Therapeutics; Foundation Medicine; Genentech; Guardant Health; InVitae; Istari Oncology; Janssen; Jiangsu Yahong Meditech; MDxHealth; Medivation; Merck; MT Group; Myovant Sciences; Myriad Genetics; Novartis; Nymox; OncoCellMDx; ORIC Pharmaceuticals; pacific edge; Palette Life Sciences; Pfizer; Plexxikon; POINT Biopharma; Propella Therapeutics; Propella Therapeutics; RhoVac; Sanofi; SeaGen; Sesen Bio; Steba Biotech; Theralase; Tolmar; Urogen pharma; Urotronic; US Biotest; Vaxiion; Veru; Zenflow